BR112022008559A2 - Bactéria produtora de serotonina - Google Patents

Bactéria produtora de serotonina

Info

Publication number
BR112022008559A2
BR112022008559A2 BR112022008559A BR112022008559A BR112022008559A2 BR 112022008559 A2 BR112022008559 A2 BR 112022008559A2 BR 112022008559 A BR112022008559 A BR 112022008559A BR 112022008559 A BR112022008559 A BR 112022008559A BR 112022008559 A2 BR112022008559 A2 BR 112022008559A2
Authority
BR
Brazil
Prior art keywords
serotonin
bacterial strain
culture medium
bacteria
lactic acid
Prior art date
Application number
BR112022008559A
Other languages
English (en)
Inventor
Grasset Estelle
Khan Muhammad
Möllstam Bo
Roos Stefan
Original Assignee
Biogaia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaia Ab filed Critical Biogaia Ab
Publication of BR112022008559A2 publication Critical patent/BR112022008559A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045Culture media therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • C12R2001/25Lactobacillus plantarum

Abstract

BACTÉRIA PRODUTORA DE SEROTONINA. A invenção se refere a seleção de cepa bacteriana para uso no tratamento de deficiência de serotonina e / ou uma doença relacionada a deficiência de serotonina pelo cultivo de bactérias de uma cepa bacteriana produtora de ácido lático, em condições aeróbicas, em um meio de cultura compreendendo triptofano. Qualquer serotonina produzida pelas bactérias da cepa bacteriana produtora de ácido lático no meio de cultura é detectada e a cepa bacteriana produtora de ácido lático é selecionada tal como eficaz no tratamento de deficiência de serotonina e / ou uma doença relacionada a deficiência de serotonina em um indivíduo se a serotonina é detectada no meio de cultura.
BR112022008559A 2019-11-08 2020-11-06 Bactéria produtora de serotonina BR112022008559A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1951292 2019-11-08
PCT/SE2020/051075 WO2021091474A1 (en) 2019-11-08 2020-11-06 Serotonin producing bacteria

Publications (1)

Publication Number Publication Date
BR112022008559A2 true BR112022008559A2 (pt) 2022-08-09

Family

ID=73449153

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112022008559A BR112022008559A2 (pt) 2019-11-08 2020-11-06 Bactéria produtora de serotonina

Country Status (19)

Country Link
US (1) US20220354909A1 (pt)
EP (2) EP4253571A3 (pt)
JP (1) JP2023501358A (pt)
KR (1) KR20220094211A (pt)
CN (1) CN114729299A (pt)
AU (1) AU2020379517A1 (pt)
BR (1) BR112022008559A2 (pt)
CA (1) CA3159798A1 (pt)
CL (1) CL2022001042A1 (pt)
CO (1) CO2022005107A2 (pt)
EC (1) ECSP22045408A (pt)
ES (1) ES2961551T3 (pt)
HR (1) HRP20231084T1 (pt)
HU (1) HUE063707T2 (pt)
IL (1) IL292709B2 (pt)
MX (1) MX2022005064A (pt)
PL (1) PL3897836T3 (pt)
WO (1) WO2021091474A1 (pt)
ZA (1) ZA202204539B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3089187A1 (en) * 2018-02-02 2019-08-08 Kobiolabs, Inc Lactobacillus plantarum kbl396 strain and use thereof
CN117187342A (zh) * 2022-09-27 2023-12-08 合肥瀚微生物科技有限公司 一种基于质谱检测肠道内单个细菌代谢物的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2826808B2 (ja) * 1995-07-14 1998-11-18 カルピス株式会社 脳機能改善、学習能力増強および記憶力増強作用を有する機能性食品
FI126711B (fi) * 2011-10-12 2017-04-13 Gut Guide Oy Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
WO2016036615A1 (en) * 2014-09-03 2016-03-10 California Institute Of Technology Microbe-based modulation of serotonin biosynthesis
MA45288A (fr) * 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
CN107523526B (zh) * 2017-10-17 2020-05-12 无限极(中国)有限公司 一种罗伊氏乳杆菌及其用途
CA3089187A1 (en) * 2018-02-02 2019-08-08 Kobiolabs, Inc Lactobacillus plantarum kbl396 strain and use thereof

Also Published As

Publication number Publication date
AU2020379517A1 (en) 2022-05-26
CL2022001042A1 (es) 2022-11-11
ES2961551T3 (es) 2024-03-12
IL292709A (en) 2022-07-01
ZA202204539B (en) 2023-11-29
EP4253571A2 (en) 2023-10-04
CA3159798A1 (en) 2021-05-14
EP3897836C0 (en) 2023-08-16
EP4253571A3 (en) 2023-12-13
KR20220094211A (ko) 2022-07-05
PL3897836T3 (pl) 2023-10-30
CN114729299A (zh) 2022-07-08
CO2022005107A2 (es) 2022-05-10
WO2021091474A1 (en) 2021-05-14
HRP20231084T1 (hr) 2023-12-22
IL292709B1 (en) 2023-10-01
ECSP22045408A (es) 2022-07-29
EP3897836B1 (en) 2023-08-16
EP3897836A1 (en) 2021-10-27
MX2022005064A (es) 2022-05-18
HUE063707T2 (hu) 2024-01-28
JP2023501358A (ja) 2023-01-18
IL292709B2 (en) 2024-02-01
US20220354909A1 (en) 2022-11-10

Similar Documents

Publication Publication Date Title
AR113011A1 (es) Vesículas extracelulares bacterianas
MX2018012553A (es) Metodos para mejorar la produccion agricola de aves de corral mediante la administracion de consorcios microbianos o cepas purificadas de los mismos.
BR112013011263A2 (pt) "composição nematicida, e método para controlar nematódeos"
BR112015023330B8 (pt) Inóculo
CL2021002602A1 (es) Células microbianas, métodos para producir las mismas, y usos de las mismas (divisional de la solicitud no. 201902135)
BR112017001910A2 (pt) uso de bacillus methylotrophicus como estimulante do crescimento vegetal e meio de controle biológico e cepas isoladas desta espécie
BR112022008559A2 (pt) Bactéria produtora de serotonina
MX2018012003A (es) Composiciones producidas por microorganismos con actividad estimuladora sobre las plantas.
BR112014010448A2 (pt) microorganismos e métodos para a produção de caprolactona
MX2022007775A (es) Composición para usarse en terapia de microbiota.
BR112017026276A2 (pt) ?método para produção de ácido a-hidromucônico?
AR100101A1 (es) Cepas de streptomyces microflavus y métodos de uso de las mismas para controlar enfermedades y plagas en plantas
CY1110624T1 (el) Βακτηριακη καλλιεργεια που εχει αποτελεσματα καταστολης της αναπτυξης δερματιτιδας και επιταχυνσης της ιασης των πληγων του δερματος, και προϊον που την χρησιμοποιει
EP2421539A4 (en) METHODS OF TREATING BACTERIAL PULMONARY INFECTION USING FLUOROQUINOLONES
BR112017014225A2 (pt) cultura biologicamente pura de lactobacillus reuteri, cepas lactobacillus reuteri, composição de uso de uma ou mais cepas de bactérias do ácido láctico, e da composição, e, método para administração tópica de cepas de bactérias do ácido láctico.
BR112016028185A2 (pt) método para produzir um l-aminoácido.
MX2021014202A (es) Metodos y composiciones para la fermentacion bacteriana anaerobia.
AR127173A2 (es) Composición agrícola para prevenir o controlar enfermedades de plantas
UA129963U (uk) Спосіб визначення антибактеріальної активності меду відносно до escherichia coli
UA104445U (uk) Спосіб тривалого зберігання анаеробних мікроорганізмів
PL430168A1 (pl) Szczepy bakteriofagów specyficzne wobec bakterii należących do rodzaju Salmonella oraz ich zastosowanie do wytwarzania preparatów zwalczających bakterie patogenne
UA128702U (uk) Штам бактерій е.coli o157:k-88 для виготовлення формолвакцини полівалентної гідроокисалюмінієвої проти ешерихіозу (колібактеріозу) поросят
UA108124U (uk) Спосіб виробництва комплексного біопрепарату фунгіцидної дії трихопсин з ентомоцидними і рістстимулюючими властивостями
UA123122U (uk) Спосіб одержання метаболітів пробіотичних штамів бактерій
UA129686U (uk) Спосіб визначення антибактеріальної активності меду відносно до proteus vulgaris